帮助 关于我们

返回检索结果

Monocarbonyl curcumin analog A2 potently inhibits angiogenesis by inducing ROS-dependent endothelial cell death

查看参考文献33篇

Liu Bin 1   Cui Liusu 2   Zhou Bo 3   Zhang Lingling 1   Liu Zhihui 1   Zhang Lu 1 *  
文摘 Excessive and abnormal vessel growth plays a critical role in the pathogenesis of many diseases, such as cancer.Angiogenesis is one of the hallmarks of cancer growth, invasion, and metastasis.Discovery of novel antiangiogenic agents would provide new insights into the mechanisms of angiogenesis, as well as potential drugs for cancer treatment.In the present study, we investigated the antiangiogenic activity of a series of monocarbonyl analogs of curcumin synthesized previously in our lab.We found that curcumin analog A2 displayed the full potential to be developed as a novel antiangiogenic agent.Curcumin analog A2 at and above 20 μM dramatically inhibited the migration and tube formation of human umbilical vein endothelial cells(HUVECs)in vitro, new microvessels sprouting from the rat aortic rings ex vivo and newly formed microvessels in chicken chorioallantoic membranes(CAMs)and Matrigel plus in vivo.We further demonstrated that curcumin analog A2 exerted its antiangiogenic activity mainly through inducing endothelial cell death via elevating NADH/NADPH oxidase-derived ROS.Curcumin analog A2 at the antiangiogenic concentrations also triggered autophagy in HUVECs, but this process is neither a pre-requisite for toxicity, leading to the cell death nor a protective response against the toxicity of curcumin analog A2.In conclusion, we demonstrate for the first time the potent antiangiogenic activity of the monocarbonyl curcumin analog A2, which could serve as a promising potential therapeutic agent for the prevention and treatment angiogenesis-related diseases, such as cancer.
来源 Acta Pharmacologica Sinica ,2019,40(11):1412-1423 【核心库】
DOI 10.1038/s41401-019-0224-x
关键词 monocarbonyl curcumin analog ; angiogenesis ; apoptosis ; autophagy ; necroptosis ; reactive oxygen species ; vascular endothelial cell ; bafilomycin A1 ; wortmannin
地址

1. College of Bioengineering, Henan University of Technology, Zhengzhou, 450001  

2. Morphological laboratory, Xinxiang Medical University, Xinxiang, 453003  

3. Lanzhou University, State Key Laboratory of Applied Organic Chemistry, Lanzhou, 730000

语种 英文
文献类型 研究性论文
ISSN 1671-4083
学科 医药、卫生
基金 国家自然科学基金 ;  the Foundation for Key Teacher by Henan University of Technology ;  the Research Program for Science and Technology of Henan Province
文献收藏号 CSCD:6609381

参考文献 共 33 共2页

1.  Potente M. Basic and therapeutic aspects of angiogenesis. Cell,2011,146:873-887 被引 93    
2.  De Palma M. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer,2017,17:457-474 被引 57    
3.  Hida K. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. Cancer Sci,2008,99:459-466 被引 5    
4.  Noble M E. Protein kinase inhibitors: insights into drug design from structure. Science,2004,303:1800-1805 被引 22    
5.  Rahmani A H. Role of curcumin in disease prevention and treatment. Adv Biomed Res,2018,7:38 被引 2    
6.  Shanmugam M K. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol,2017,15:503-519 被引 1    
7.  El-Azab M. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice. Eur J Pharmacol,2011,652:7-14 被引 3    
8.  Gururaj A E. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun,2002,297:934-942 被引 23    
9.  Hewlings S J. Curcumin: A review of its’effects on human health. Foods,2017,6:E92 被引 21    
10.  Shimazu K. Curcumin analog GOY078, overcomes resistance to tumor angiogenesis inhibitors. Cancer Sci,2018,109:3285-3293 被引 1    
11.  Sugiyama S. A curcumin analog, GO-Y078, effectively inhibits angiogenesis through actin disorganization. Anticancer Agents Med Chem,2016,16:633-647 被引 1    
12.  Sun L. Potent anti-angiogenicactivity of B19—a mono-carbonyl analogue of curcumin. Chin J Nat Med,2014,12:8-14 被引 2    
13.  Zhao C. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). Curr Pharm Des,2013,19:2114-2135 被引 5    
14.  Pan Z. Synthesis and cytotoxic evaluation of monocarbonyl analogs of curcumin as potential anti-tumor agents. Drug Dev Res,2016,77:43-49 被引 1    
15.  Pignanelli C. Selective targeting of cancer cells by oxidative vulnerabilities with novel curcumin analogs. Sci Rep,2017,7:1105 被引 1    
16.  Song J X. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy,2016,12:1372-1389 被引 15    
17.  Jaffe E A. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest,1973,52:2745-2756 被引 277    
18.  Zhang L. 3,4-Dimethoxystilbene, a resveratrol derivative with anti-angiogenic effect, induces both macroautophagy and apoptosis in endothelial cells. J Cell Biochem,2013,114:697-707 被引 1    
19.  Zhang L. Magnetic ferroferric oxide nanoparticles induce vascular endothelial cell dysfunction and inflammation by disturbing autophagy. J Hazard Mater,2016,304:186-195 被引 5    
20.  Zhang L. Novel role for TRPC4 in regulation of macroautophagy by a small molecule in vascular endothelial cells. Biochim Biophys Acta,2015,1853:377-387 被引 3    
引证文献 1

1 沙芳芳 基于CRISPR/Cas9构建血管平滑肌细胞特异性Mrjp1基因敲入小鼠 中国畜牧兽医,2023,50(11):4392-4402
被引 0 次

显示所有1篇文献

论文科学数据集
PlumX Metrics
相关文献

 作者相关
 关键词相关
 参考文献相关

版权所有 ©2008 中国科学院文献情报中心 制作维护:中国科学院文献情报中心
地址:北京中关村北四环西路33号 邮政编码:100190 联系电话:(010)82627496 E-mail:cscd@mail.las.ac.cn 京ICP备05002861号-4 | 京公网安备11010802043238号